{"id":"W1831380443","doi":"10.3747/co.2007.132","title":"Phase II Testing of Sunitinib: The National Cancer Institute of Canada Clinical Trials Group IND Program Trials IND.182–185","year":2007,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Queen's University; Cancer Care Ontario; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Sunitinib; Clinical trial; Bevacizumab; Vascular endothelial growth factor; Oncology; Angiogenesis; Internal medicine; PDGFRA; Tyrosine-kinase inhibitor; Cancer research; Cancer; Chemotherapy; VEGF receptors; Stromal cell; GiST","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01209098,0.0001712411,0.00144607,0.0001026747,0.0001159526,0.000004923138,0.0001333626,0.0001566532,0.0001153789],"category_scores_gemma":[0.01968674,0.0001027046,0.0002238915,0.0003462168,0.0003099706,0.00004062756,0.00006944174,0.0002316578,9.071027e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005917163,"about_ca_system_score_gemma":0.005780588,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01815551,"about_ca_topic_score_gemma":0.08040064,"domain_scores_codex":[0.9958087,0.0007541335,0.002377188,0.000254289,0.0005011286,0.000304531],"domain_scores_gemma":[0.989708,0.007713576,0.0015275,0.0001669145,0.0006951445,0.000188864],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001057681,0.01229745,0.06062284,0.00007620318,0.0004481698,0.00002856693,0.0001463599,0.000002715667,0.0001314438,0.000993713,0.01146283,0.912732],"study_design_scores_gemma":[0.04342874,0.008932797,0.09502322,0.0004122037,0.001077523,0.00004004383,0.000171356,0.00007632953,0.002378703,0.0001762973,0.8481133,0.0001694787],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885066,0.001983472,0.00002136199,0.001351794,0.00370636,0.001906863,0.0002026162,0.0000190239,0.00230192],"genre_scores_gemma":[0.9970418,0.0002484984,0.0005787755,0.0002773007,0.00141541,0.0002909246,0.0001102895,0.00001066238,0.0000263774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9125625,"threshold_uncertainty_score":0.9998557,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6175286996166528,"score_gpt":0.6092700241267817,"score_spread":0.008258675489871137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}